Lv5
1580 积分 2024-06-06 加入
Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
2天前
已完结
Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4
2天前
已完结
From Hit to Lead: Discovery of First-In-Class Furanone Glycoside D228 Derived from Chimonanthus salicifolius for the Treatment of Inflammatory Bowel Disease
2天前
已完结
Discovery and Hit to Lead Optimization of Macrocyclic Peptides as Novel Tropomyosin Receptor Kinase A Antagonists
2天前
已完结
Ageing, Neurodegeneration and the Endocannabinoid System
2天前
已完结
Drug Discovery Toxicology
5天前
已完结
In vitro toxicology: Next generation models and methods to improve safety evaluation
5天前
已完结
Efficacy and safety of incretin co-agonists: Transformative advances in cardiometabolic healthcare
6天前
已完结
Cannabinoid-Based Medicines and Multiple Sclerosis
8天前
已完结
Dysregulation of the endocannabinoid system – a key factor in the progression of multiple sclerosis?
12天前
已关闭
皖公网安备34019202002308
